Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Paul Wadwa

Showing results (1-10 of 142) with videos related to

Pageof 15
Sort By:
Reviews in Endocrine & Metabolic Disorders|December 13, 2006
Cardiovascular disease risk in youth with diabetes mellitusR Paul Wadwa
Current Opinion in Endocrinology, Diabetes, and Obesity|October 18, 2007
Noninvasive measures of cardiovascular changes in diabetes mellitusR Paul Wadwa
Current Diabetes Reports|May 7, 2014
Risks and benefits of statin use in young people with type 1 diabetesPetter Bjornstad, R Paul Wadwa
Current Opinion in Endocrinology, Diabetes, and Obesity|July 1, 2022
The future of telehealth in type 1 diabetesErin C Cobry, R Paul Wadwa
Diabetes Technology & Therapeutics|June 2, 2012
Hypoglycemia, diabetes, and cardiovascular diseaseJanet K Snell-Bergeon, R Paul Wadwa
Expert Review of Medical Devices|November 1, 2025
An overview of the t:slim X2 and Mobi insulin pumps with Control-IQ technology: patient safety and device efficacyAlexandra Sawyer, Gregory P Forlenza, R Paul Wadwa
Diabetes Care|February 24, 2022
Improvements in Parental Sleep, Fear of Hypoglycemia, and Diabetes Distress With Use of an Advanced Hybrid Closed-Loop SystemErin C Cobry, Alessandro Bisio, R Paul Wadwa, et al.
Journal of Child Neurology|September 15, 2006
Maternal risk factors for term neonatal seizures: population-based study in Colorado, 1989-2003Deborah A Hall, R Paul Wadwa, Neil A Goldenberg, et al.
Diabetes Technology & Therapeutics|June 21, 2018
Performance of a Factory-Calibrated Real-Time Continuous Glucose Monitoring System Utilizing an Automated Sensor ApplicatorViral N Shah, Lori M Laffel, R Paul Wadwa, et al.
Diabetes Technology & Therapeutics|June 15, 2018
Accuracy of a Factory-Calibrated, Real-Time Continuous Glucose Monitoring System During 10 Days of Use in Youth and Adults with DiabetesR Paul Wadwa, Lori M Laffel, Viral N Shah, et al.
Pageof 15

Showing results (1-10 of 142) with videos related to

Sort By:
Pageof 15
Reviews in Endocrine & Metabolic Disorders|December 13, 2006
Cardiovascular disease risk in youth with diabetes mellitusR Paul Wadwa
Current Opinion in Endocrinology, Diabetes, and Obesity|October 18, 2007
Noninvasive measures of cardiovascular changes in diabetes mellitusR Paul Wadwa
Current Diabetes Reports|May 7, 2014
Risks and benefits of statin use in young people with type 1 diabetesPetter Bjornstad, R Paul Wadwa
Current Opinion in Endocrinology, Diabetes, and Obesity|July 1, 2022
The future of telehealth in type 1 diabetesErin C Cobry, R Paul Wadwa
Diabetes Technology & Therapeutics|June 2, 2012
Hypoglycemia, diabetes, and cardiovascular diseaseJanet K Snell-Bergeon, R Paul Wadwa
Expert Review of Medical Devices|November 1, 2025
An overview of the t:slim X2 and Mobi insulin pumps with Control-IQ technology: patient safety and device efficacyAlexandra Sawyer, Gregory P Forlenza, R Paul Wadwa
Diabetes Care|February 24, 2022
Improvements in Parental Sleep, Fear of Hypoglycemia, and Diabetes Distress With Use of an Advanced Hybrid Closed-Loop SystemErin C Cobry, Alessandro Bisio, R Paul Wadwa, et al.
Journal of Child Neurology|September 15, 2006
Maternal risk factors for term neonatal seizures: population-based study in Colorado, 1989-2003Deborah A Hall, R Paul Wadwa, Neil A Goldenberg, et al.
Diabetes Technology & Therapeutics|June 21, 2018
Performance of a Factory-Calibrated Real-Time Continuous Glucose Monitoring System Utilizing an Automated Sensor ApplicatorViral N Shah, Lori M Laffel, R Paul Wadwa, et al.
Diabetes Technology & Therapeutics|June 15, 2018
Accuracy of a Factory-Calibrated, Real-Time Continuous Glucose Monitoring System During 10 Days of Use in Youth and Adults with DiabetesR Paul Wadwa, Lori M Laffel, Viral N Shah, et al.
Pageof 15